Stay updated with breaking news from Prevention Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preliminary findings from two clinical trials in South Africa suggest that the omicron variant of the virus that causes COVID-19 may have a much higher rate of
The Citizen's top 10 most-read stories of the week.
The Citizen's top five most-read stories of the work week.
(Bloomberg) -- Moderna Inc. will start a trial of its Covid-19 vaccine across eight African countries to determine its efficacy in people who are HIV positive.
"I think we helped a lot of people. And if we didn't help them directly, we planted seeds. ... When people have that epiphany and they change, it's a wonderful